Clinical trial
Deep Repetitive Transcranial Magnetic Stimulation in the Treatment of Tinnitus
NCT07885176 is registered in ClinicalTrials.gov with University of Regensburg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Deep Repetitive Transcranial Magnetic Stimulation in the Treatment of Tinnitus
- Lead sponsor
- University of Regensburg
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 19, 2026
- Completion date
- August 31, 2029
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
tinnitus, tinnitus, bilateral
Arms
As registered; 3 arms.
-
H1-coil
18 Hz, 2000 pulses
-
H4-coil
1 Hz, 2000 pulses
-
H7-coil
18 Hz, 2000 pulses placebo
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Changes in Tinnitus Burden
Changes in Tinnitus Burden Measured Using the Tinnitus Handicap Inventory (THI) from Baseline to the End of Treatment, Including Group Comparisons.
The THI consists of 25 items designed to evaluate the perceived impact of tinnitus on an individual's daily life. Each item provides three response options: 'No', 'Sometimes' and 'Yes', which are scored as 0, 2 and 4 points respectively. The total THI score is obtained by summing the scores of all items, resulting in a score that ranges from 0 to 100, with higher scores indicating greater perceived handicap due to tinnitus.
Lead sponsor's other trials
University of Regensburg, most recent start first.
+65 more trials See the organization page
Similar trials
Same condition (Tinnitus) and phase, most recent start first.
+260 more trials See the condition page